Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Approval recommended for Elan's gel formulation of diazepam

Nov. 21, 1996

No Comments

SIBIA Neurosciences reports preclinical results with NAChR-selective compounds

Nov. 21, 1996

No Comments

NIH to conduct clinical trial of Ampalex in AD

Nov. 21, 1996

No Comments

First pivotal trial for panic disorder Rx

Nov. 20, 1996

No Comments

Cephalon/Leo neurological disease collaboration

Nov. 20, 1996

No Comments

Antimigraine drug from Vanguard to enter pivotal trials

Nov. 20, 1996

No Comments

Peripheral opiate antihyperalgesic from Adolor in clinical trials

Nov. 20, 1996

No Comments

SKB reports D3-selective antipsychotic agents

Nov. 20, 1996

No Comments

Analgesic kappa-opioid agonists reported by Pfizer

Nov. 20, 1996

No Comments

Daiichi discloses cerebroprotective agents

Nov. 15, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Approval recommended for Elan's gel formulation of diazepam

SIBIA Neurosciences reports preclinical results with NAChR-selective compounds

NIH to conduct clinical trial of Ampalex in AD

First pivotal trial for panic disorder Rx

Cephalon/Leo neurological disease collaboration

Antimigraine drug from Vanguard to enter pivotal trials

Peripheral opiate antihyperalgesic from Adolor in clinical trials

SKB reports D3-selective antipsychotic agents

Analgesic kappa-opioid agonists reported by Pfizer

Daiichi discloses cerebroprotective agents

Today's news in brief

Today's news in brief

Boryung invests $10M in Intuitive Machines for outer space R&D

Phase II Huntington’s tie-up with Novartis could edge $3B for PTC

Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal

Neurology/psychiatric RSS

Neurology/psychiatric
RSS